Clinical tools

Live nowPending clinical review

Setu Kinetics

Put an isolated lab change in context: the liver injury pattern, whether a creatinine rise meets KDIGO AKI criteria, where the eGFR trend is heading, and how long a value takes to fall once the injury stops.

New here? See the one-minute guide and try it with sample data →

Air-gapped: no patient data leaves this browser.

There is no server, no login, and no logging. The page cannot make network requests. Close the tab or press Clear to remove everything from memory.

Loading Setu Kinetics…

Liver pattern

Enter what you have. ULNs vary by lab: use your lab’s values.

Same unit as its ULN.

Upper limits of normal (AST 40, ALT 40, ALP 120, bilirubin 1.2)

1.2 mg/dL default; about 21 µmol/L.

  • AST–
  • ALT–
  • ALP–
  • Bilirubin–

De Ritis ratio (AST/ALT)

Enter AST and ALT.

Source: ACG 2017 (Kwo)

R factor

Enter ALT and ALP.

Sources: ACG 2017 (Kwo); LiverTox (NIDDK)

Verify before use: decision support only. Confirm against the lab’s own reference ranges, current KDIGO, ACG, and FDA guidance, and the patient.

Creatinine change and KDIGO AKI

Baseline known or presumed within the prior 7 days. Times matter: the 0.3 rise counts only within 48 h.

Unit for every creatinine on this page (µmol/L ÷ 88.4 = mg/dL).

Urine output (optional)

Enter baseline and current creatinine with their times, or urine output.

Sources: KDIGO 2012 AKI guideline; Waikar 2009 (creatinine kinetics)

KDIGO 2012 staging table
KDIGO 2012 AKI stages by serum creatinine and urine output
StageSerum creatinineUrine output
11.5–1.9× baseline, or rise ≥ 0.3 mg/dL (≥ 26.5 µmol/L) within 48 h< 0.5 mL/kg/h for 6–12 h
22.0–2.9× baseline< 0.5 mL/kg/h for ≥ 12 h
3≥ 3.0× baseline, or SCr ≥ 4.0 mg/dL (≥ 353.6 µmol/L), or start of KRT< 0.3 mL/kg/h for ≥ 24 h, or anuria ≥ 12 h

Verify before use: decision support only. Confirm against the lab’s own reference ranges, current KDIGO, ACG, and FDA guidance, and the patient.

eGFR trajectory (CKD-EPI 2021)

Race-free equation for adults at steady state. Paste dated creatinine values, one per line.

Whole years, 18 or older. Earlier ages are worked back from the dates.

One per line: date then value, like “2025-03-01, 1.1” or “3/1/2025 1.1”.

Paste at least one dated value.

Sources: Inker 2021 (CKD-EPI 2021); NIDDK: GFR equations; KDIGO 2024 CKD guideline

Verify before use: decision support only. Confirm against the lab’s own reference ranges, current KDIGO, ACG, and FDA guidance, and the patient.

Half-life context

If the injury stopped now, about how long until the value falls? Approximate, population averages.

Often the ULN.

Enter a current value and a target.

Approximate serum half-lives and how to read them
TestApproximate half-lifeSource
ALTAbout 47 hours (plus or minus 10). ALT falls more slowly than AST, so the AST/ALT ratio drops during recovery.Dufour 2000 (Clin Chem)
AST (total)About 17 hours (plus or minus 5) for total AST. Mitochondrial AST clears more slowly.Dufour 2000 (Clin Chem)
ALPAbout 7 days for the liver form, so ALP can stay high for a week or more after an obstruction is relieved. Intestinal ALP clears faster.ACG 2017 (Kwo)
CKAbout 1.5 days in a rhabdomyolysis cohort. A CK that keeps rising suggests ongoing muscle injury.Paternostro 2021 (CK half-life)
BilirubinVariable. Conjugated bilirubin that has bound to albumin (delta bilirubin) clears with albumin over weeks, so jaundice can lag clinical recovery.Dufour 2000 (Clin Chem)
TroponinVariable by assay and size of injury; levels can stay elevated for days after myocardial injury. Use the assay’s own rise-and-fall rules.Fourth Universal Definition of MI
CreatinineNot a half-life. After a step change in GFR, serum creatinine moves toward a new steady state over roughly 24 to 72 hours, longer when GFR is low. It lags the true change in GFR.Waikar 2009 (creatinine kinetics)

An isolated mild elevation. Repeat the test before a workup: many resolve. Ask about recent strenuous exercise or muscle injury (check CK if AST is disproportionate), new medicines, supplements and herbal products, and alcohol. Hemolysis raises AST, and macro-AST can keep it high without disease.

Sources: ACG 2017 (Kwo); Dufour 2000 (Clin Chem)

Verify before use: decision support only. Confirm against the lab’s own reference ranges, current KDIGO, ACG, and FDA guidance, and the patient.

.LABKINETICS note

Dense plain text for the chart. Only the sections you filled in are included.

Verify before use: decision support only. Confirm against the lab’s own reference ranges, current KDIGO, ACG, and FDA guidance, and the patient.

How it works

Using Setu Kinetics

  1. Liver pattern

    Enter AST, ALT, ALP, and bilirubin with your lab’s ULNs. See fold over ULN, the De Ritis ratio, the R factor, and a Hy’s-law-style flag.

  2. Creatinine and AKI

    Enter a baseline and a current creatinine with their times, plus urine output if you have it. Kinetics applies the KDIGO 48-hour and 7-day windows and stages the injury.

  3. eGFR trajectory

    Paste dated creatinine values. Each gets a CKD-EPI 2021 eGFR and G category, and the trend gets a least-squares slope with KDIGO flags.

  4. Half-life and note

    Estimate how long a value takes to reach the ULN if release stopped, then copy the .LABKINETICS note.

Questions

Common questions about Setu Kinetics

Which eGFR equation does it use?

The 2021 CKD-EPI creatinine equation without a race term (Inker et al., NEJM 2021), as recommended by the NKF-ASN Task Force and NIDDK. It is for adults at steady state; it is not valid during AKI.

Why do the ULN boxes matter?

Fold over ULN, the R factor, and the Hy’s-law flag all divide by the ULN, and labs differ (an ALT ULN of 33 or 56 U/L changes the answer). The defaults are placeholders; use your lab’s values.

How are the KDIGO time windows handled?

A rise of 0.3 mg/dL counts only within 48 hours, and 1.5 times baseline only within 7 days, both inclusive. Values more than 7 days apart are flagged as outside the AKI definition, pointing to AKD or CKD instead.

What counts as rapid eGFR decline?

A sustained fall of more than 5 mL/min/1.73 m² per year (KDIGO 2024), or a drop in G category with a fall of 25% or more from baseline. A slope from fewer than three values or under a year is marked as rough.

Is anything saved?

No. Everything stays in this tab’s memory. Clear or leaving the page wipes it, and the page cannot send data anywhere.

Sources

Where Setu Kinetics’s rules come from

Guidelines change. Always check the current version and the product label before acting.

  1. KDIGO Clinical Practice Guideline for Acute Kidney Injury (2012). Kidney Int Suppl. 2012;2(1):1-138.Kidney Disease: Improving Global Outcomes. Checked October 4, 2026.
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.Kidney Disease: Improving Global Outcomes. Checked October 4, 2026.
  3. Inker LA, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749.New England Journal of Medicine. Checked October 4, 2026.
  4. Glomerular Filtration Rate Equations. National Institute of Diabetes and Digestive and Kidney Diseases.National Institutes of Health. Checked October 4, 2026.
  5. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.American College of Gastroenterology. Checked October 4, 2026.
  6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (R ratio and injury patterns).National Institutes of Health, NCBI Bookshelf. Checked October 4, 2026.
  7. Drug-Induced Liver Injury: Premarketing Clinical Evaluation. Guidance for Industry (2009).U.S. Food and Drug Administration. Checked October 4, 2026.
  8. Dufour DR, et al. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem. 2000;46(12):2027-2049.Clinical Chemistry. Checked October 4, 2026.
  9. Paternostro C, et al. Incidence and clinical spectrum of rhabdomyolysis in general neurology: a retrospective cohort study. Neuromuscul Disord. 2021.Neuromuscular Disorders. Checked October 4, 2026.
  10. Thygesen K, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264.Journal of the American College of Cardiology. Checked October 4, 2026.
  11. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol. 2009;20(3):672-679.Journal of the American Society of Nephrology. Checked October 4, 2026.

Keep going

Menu